SEC Form 4 · accession 0001203311-16-000161
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan G Drachman
Officer — CMO & EVP, R & D
Period of report
Sep 22, 2016
Accepted (ET)
Sep 23, 2016 · 7:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 22, 2016 | M | 2,249 | $10.29 | A | 115,504 | D | |
| Common StockF2 | Sep 22, 2016 | S | 2,249 | $56.75 | D | 113,255 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $10.29 | Sep 22, 2016 | M | 2,249 | D | — | Aug 28, 2017 | Common Stock | 2,249 | 30,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F3Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.